Next PDUFA, MDUFA Hearings Scheduled for 18 April

The House Energy and Commerce Committee announced it will hearing testimony on the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA) reauthorization bills on 18 April.

The hearing, entitled "US Food and Drug Administration User Fees 2012: How Innovation Helps Patients and Jobs," will be taking place at 10:15 am in 2123 Rayburn House Office Buildings.

A webcast of the meeting will be available at http://republicans.energycommerce.house.gov/ on the day of the meeting. The hearings are typically archived on the Committee's YouTube account.

Prior committee hearings include:

• 8 March - FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain
• 1 March - Prescription Drug Diversion: Combating the Scourge
• 17 February - Impact of Medical Device Regulation on Jobs and Patients
• 15 February - Reauthorization of MDUFA: What It Means for Jobs, Innovation and Patients
• 9 February - Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages
• 1 February - Reauthorization of PDUFA: What It Means for Jobs, Innovation, and Patients

Read more:

E&C - FDA User Fees 2012: How Innovation Helps Patients and Jobs